Commentary

Video

50 years of ophthalmology: What changed the game (Part 1)

In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.

As Ophthalmology Times celebrates its 50th anniversary, the American Society of Cataract and Refractive Surgery (ASCRS) 2025 annual meeting in Los Angeles, California, provided the perfect backdrop to reflect on the transformational innovations that have shaped ophthalmology over the last half-century. Ophthalmologists shared their insights on the profession’s evolution, celebrating technological advances and paradigm shifts that continue to define modern eye care.

“Fifty years is a long time!” exclaimed Cynthia Matossian, MD. “A lot has changed in ophthalmology in five decades.” One of the most profound changes she noted is the increased representation of women in the field. “There were very, very few women, let alone women in leadership positions… now, fortunately, that landscape has changed.”

Technology emerged as a central theme. Matossian highlighted advances in diagnostics and treatment, from imaging tools to therapeutics for dry eye and retinal disease. “Dry eye wasn’t a thing back then,” she recalled, “and now it’s a whole new category in and of itself.”

Phacoemulsification stood out as a cornerstone of surgical innovation. “Phacoemulsification by far completely changed how we treat patients with cataract surgery,” said Mark Lobanoff, MD. “In my era,” he added, “femtosecond-assisted cataract surgery… that’s the future.”

Monique Barbour, MD, cited four major innovations: modern cataract surgery, LASIK, anti-VEGF therapies for retinal diseases, and advanced diagnostics like OCT and OCTA. “Foldable IOLs… are revolutionary,” she said, reflecting on her transition from sutures and manual expression to phaco techniques.

The excimer laser was hailed by Parag Majmudar, MD, as a game-changer in refractive surgery. “It’s an amazing, fascinating story of how innovation, persistence, and technology… created an environment where we can shape people’s vision.”

Neda Shamie, MD, summed up the sentiment well: “Each year I have access to better and better technology thanks to that rapid evolution of innovations.” These reflections celebrate not only how far ophthalmology has come, but the boundless potential that still lies ahead.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.